1. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm258700.html
2. http://www.medgadget.com/2014/08/ges-new-signa-petmr-with-time-of-flight-tech-under-review-by-fda.html
3. http://www3.gehealthcare.com/en/products/categories/molecular_imaging/pet_ct_and_mr_trimodality_imaging#tabs/tab8F8D8C24FA804C47AC2348D98A4F1971
4. Gold, LS et al. Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (Internet). Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Oct. Report No.: 14-EHC044-EF
5. Buchbender C, et al. (2012) Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen and pelvis. J Nucl Med. 53(6):928–938. doi: 10.2967/jnumed.112.105338